Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Samsung Biologics
24 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Aseptic Fill/Finish
Webinar: Capitalizing on CDMO Expertise in Aseptic Fill/Finish, Presented by Samsung Biologics
PAO-08-23-PATV-02
CDMO Partnerships
Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics
PAO-08-23-PATV-01
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
PAO-07-23-RT-01
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
PAO-07-23-RT-02
CDMO Partnerships
Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
PAO-05-23-CL-07
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
PR-M03-23-05
mRNA Ultra-Cold Chain Management
Ultra-Cold Chain and Supply Chain Management Strategies for mRNA
PAO-02-23-CL-09
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
PAO-01-23-RT-01
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
PAO-11-022-CL-02
Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
PR-M04-22-14
Leadership
Q: What’s the key to being a leader in the industry?
PAO-03-022-RT-02
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
PAO-03-022-RT-01
M&A
Samsung Biologics Reaches Agreement With Biogen to Acquire Full Ownership of Samsung Bioepis
PR-M01-22-21
Financial Results
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results
PR-M01-22-16
Drug Development
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
PR-M03-20-NI-007
Customer Centricity
Achieving Rapid Success with a Flexible, Client-Centric Approach
PAP-Q3-19-CL-024
Manufacturing Deal
Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal
PR-M08-19-NI-026
FDA Approval
Samsung BioLogics Receives an additional FDA Approval for its world largest Plant's Production
PR-M05-18-NI-100
Announcement
Samsung BioLogics Becomes the First in the South Korean Pharma Industry to Achieve ISO 22301 Certificate
PR-M04-18-NI-101
Ultrasound
Samsung Unveils New Innovative Ultrasound System at AIUM 2018
PR-M03-18-NI-097
Oncology
MSD Launches Herceptin Biosimilar in UK
PAO-M03-18-NI-015
Biologics
Fully Supporting Customer Needs for Biologics Development and Manufacturing
PAP-Q1-18-CL-016
Facility
First Order Reported for New Samsung Plant
PAO-M03-18-NI-001
Added Capacity
World’s Largest Biologics Plant Gets EMA Nod
PAO-M12-17-NI-029
